Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. INO
INO logo

INO

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

INO News

Inovio Pharmaceuticals Faces Class Action Lawsuit

2h agoGlobenewswire

Inovio Pharmaceuticals Shareholder Notice Issued

7h agoPRnewswire

Inovio Pharmaceuticals Faces Class Action Lawsuit Reminder

8h agoGlobenewswire

PomDoctor and Inovio Face Class Action Lawsuits

23h agoGlobenewswire

Inovio Pharmaceuticals Investors Class Action Notice

1d agoGlobenewswire

INOVIO to Participate in Key Scientific Conferences

1d agoPRnewswire

Inovio Pharmaceuticals Securities Class Action Notice

3d agoGlobenewswire

Inovio Pharmaceuticals Faces Class Action Lawsuit Reminder

4d agoGlobenewswire

Faruqi & Faruqi Investigates Inovio Investor Claims

4d agoPRnewswire

INOVIO Schedules Release of 2025 Financial Results

4d agoPRnewswire

Inovio Pharmaceuticals Faces Class Action for Investor Misleading

5d agoGlobenewswire

Class Action Lawsuits Filed for Multiple Companies

5d agoGlobenewswire

INOVIO ANTICIPATES START OF COMBINATION THERAPY DOSING TRIAL IN SECOND HALF OF 2026

6d agomoomoo

INOVIO AND AKESO PARTNER TO FURTHER DEVELOPMENT OF INNOVATIVE COMBINATION TREATMENT FOR GLIOBLASTOMA (GBM)

6d agomoomoo

Inovio Pharmaceuticals Class Action Notice Issued

6d agoPRnewswire

Inovio Pharmaceuticals Securities Class Action Notice

Mar 03 2026Globenewswire